CGPCS
Capital Group Private Client Services’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Sell |
22,872
-88,130
| -79% | -$46.3M | 0.1% | 133 |
|
|
2025
Q1 | $70.4M | Buy |
111,002
+19,672
| +22% | +$12.5M | 0.69% | 37 |
|
|
2024
Q4 | $65.1M | Sell |
91,330
-19,565
| -18% | -$13.9M | 0.6% | 44 |
|
|
2024
Q3 | $117M | Buy |
110,895
+10,667
| +11% | +$11.2M | 1.11% | 23 |
|
|
2024
Q2 | $105M | Sell |
100,228
-3,641
| -4% | -$3.83M | 1.05% | 22 |
|
|
2024
Q1 | $100M | Buy |
103,869
+10,857
| +12% | +$10.4M | 1.02% | 24 |
|
|
2023
Q4 | $81.7M | Buy |
93,012
+336
| +0.4% | +$295K | 0.84% | 32 |
|
|
2023
Q3 | $76.3M | Buy |
92,676
+26,108
| +39% | +$21.5M | 0.93% | 31 |
|
|
2023
Q2 | $47.8M | Buy |
66,568
+41,630
| +167% | +$29.9M | 0.56% | 63 |
|
|
2023
Q1 | $20.5M | Buy |
24,938
+2,048
| +9% | +$1.68M | 0.25% | 101 |
|
|
2022
Q4 | $16.5M | Buy |
22,890
+60
| +0.3% | +$43.3K | 0.21% | 114 |
|
|
2022
Q3 | $15.7M | Buy |
22,830
+82
| +0.4% | +$56.5K | 0.22% | 111 |
|
|
2022
Q2 | $13.4M | Sell |
22,748
-44
| -0.2% | -$26K | 0.17% | 120 |
|
|
2022
Q1 | $15.9M | Buy |
+22,792
| New | +$15.9M | 0.17% | 120 |
|